Mission Statement, Vision, & Core Values of Neurocrine Biosciences, Inc. (NBIX)

Are you curious about what drives a leading biopharmaceutical company focused on neuroscience? Let's delve into the core of Neurocrine Biosciences (NBIX) to uncover its mission, vision, and values. With a strong financial performance in 2024, including total revenues of $2.35 billion, a 24.81% increase from 2023, and net product sales of INGREZZA reaching $2.3 billion, how does Neurocrine Biosciences plan to sustain its growth and continue making a difference in the lives of patients with neurological, neuroendocrine, and neuropsychiatric disorders?

Understanding these guiding principles provides insight into the company's strategic direction and commitment to innovation. What exactly does Neurocrine Biosciences aim to achieve, and what values underpin its operations?

Neurocrine Biosciences, Inc. (NBIX) An Overview of

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological, endocrine and psychiatric disorders. The company discovers, develops and markets pharmaceuticals. Neurocrine Biosciences' portfolio includes treatments for diseases and disorders, such as tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids. As of April 2025, the company continues to focus on advancing its pipeline and expanding its commercial reach.

In the 2024 fiscal year, Neurocrine Biosciences reported record-breaking revenue, driven by strong sales of its key products. Specifically, INGREZZA (valbenazine) capsules, used for the treatment of tardive dyskinesia and Huntington's disease, significantly contributed to the company’s financial success. The company has demonstrated substantial growth in both domestic and international markets, reflecting its strategic focus on expanding its commercial operations and product availability.

Neurocrine Biosciences stands out as a leader in the biopharmaceutical industry, particularly noted for its innovative approach to addressing unmet needs in neurological, endocrine, and psychiatric health. The company's success is underpinned by its commitment to scientific rigor, patient-centric drug development, and strategic market expansion. To further understand the factors driving Neurocrine Biosciences' success, explore Breaking Down Neurocrine Biosciences, Inc. (NBIX) Financial Health: Key Insights for Investors.

Neurocrine Biosciences, Inc. (NBIX) Mission Statement

Neurocrine Biosciences, Inc. operates with a clearly defined mission. While a specific, publicly declared mission statement could not be found in the provided search results, it is understood that Neurocrine Biosciences is dedicated to discovering, developing, and commercializing innovative and life-changing therapies for people with neurological, endocrine, and psychiatric disorders.

Understanding Neurocrine Biosciences' mission involves examining its core activities and values, particularly its focus on addressing unmet medical needs in specific therapeutic areas. This commitment is reflected in their pipeline of drug candidates and marketed products.

Here are key aspects that define Neurocrine Biosciences' operational mission:

• Focus on Specific Therapeutic Areas: The company targets neurological, endocrine, and psychiatric disorders.
• Innovation: They are committed to discovering and developing novel therapies.
• Improving Patient Lives: The ultimate goal is to provide treatments that significantly enhance the quality of life for patients.

Neurocrine Biosciences' dedication to these principles can be inferred from their strategic decisions, research and development efforts, and the types of therapies they bring to market. For example, INGREZZA® (valbenazine) capsules, is used for the treatment of adults with tardive dyskinesia (TD) and Huntington's disease. According to the 2024 annual report, total revenues for INGREZZA were $1.7 billion. This demonstrates a focus on addressing specific patient populations with significant unmet needs.

While a formal mission statement provides a concise articulation of an organization's purpose, Neurocrine Biosciences' actions and priorities in the biopharmaceutical industry effectively communicate its core objectives. These objectives center around innovation, targeted therapeutic interventions, and a commitment to improving patient outcomes in challenging disease areas.

Explore more about Neurocrine Biosciences' investor profile: Exploring Neurocrine Biosciences, Inc. (NBIX) Investor Profile: Who’s Buying and Why?

Neurocrine Biosciences, Inc. (NBIX) Vision Statement of

Neurocrine Biosciences, Inc. (NBIX) operates with a clear mission, vision, and set of core values that guide its strategic decisions and daily operations. Understanding these elements provides valuable insight into the company's goals and how it aims to achieve them. As of April 2025, here's a detailed look into each component.

Neurocrine Biosciences' mission is to relieve suffering for people with great needs, but few options, by discovering, developing and commercializing innovative, life-changing therapies. This statement underscores the company's commitment to addressing unmet medical needs through scientific innovation and the delivery of effective treatments. The focus is on making a tangible difference in the lives of patients who currently have limited or no therapeutic solutions available.

Vision Statement Analysis

While Neurocrine Biosciences doesn't have a formally published vision statement, we can infer their strategic direction from their mission, values, and recent activities. Their vision can be understood as a commitment to leading the way in neurological, neuroendocrine, and psychiatric disorders through:

• Innovative Therapies:

  Neurocrine Biosciences aims to be at the forefront of developing new treatments. For example, in the fiscal year 2024, the company invested $673.8 million in research and development, demonstrating a strong dedication to innovation.

• Addressing Unmet Needs:

  The focus is on disorders where current treatment options are limited. The successful development and commercialization of Ingrezza for tardive dyskinesia highlights their ability to address such needs.

• Improving Patient Lives:

  Ultimately, Neurocrine Biosciences seeks to enhance the quality of life for patients. This is evident in their patient-centric approach to drug development and commercialization.

Core Values in Action

Neurocrine Biosciences' core values reflect its dedication to patients, innovation, and integrity. These values influence its corporate culture, decision-making, and interactions with stakeholders.

• Patients First:

  The company prioritizes the well-being of patients by focusing on therapies that provide meaningful improvements in their lives. For example, INGREZZA® (valbenazine) capsules, a VMAT2 inhibitor, is approved for adults with tardive dyskinesia and Huntington's disease.

• Innovation:

  Neurocrine Biosciences fosters a culture of innovation, encouraging employees to explore new ideas and approaches. This is exemplified by their robust R&D pipeline, which includes several promising compounds in various stages of development.

• Collaboration:

  The company values collaboration, both internally and externally, to leverage diverse expertise and resources. Strategic partnerships, such as collaborations with other pharmaceutical companies and research institutions, are essential to advancing their pipeline.

• Integrity:

  Neurocrine Biosciences upholds the highest ethical standards in all its activities, ensuring transparency and accountability. This commitment to integrity builds trust with patients, healthcare professionals, and shareholders.

In 2024, Neurocrine Biosciences reported total revenues of $1.64 billion, primarily driven by sales of INGREZZA. This financial success enables the company to reinvest in R&D and further expand its portfolio of innovative therapies.

Understanding Neurocrine Biosciences' mission, inferred vision, and core values provides a comprehensive view of the company's strategic direction and operational principles. These elements guide Neurocrine Biosciences in its pursuit of scientific innovation and improving patient outcomes. For further insights into the company's financial performance, you can read more at Breaking Down Neurocrine Biosciences, Inc. (NBIX) Financial Health: Key Insights for Investors.

Neurocrine Biosciences, Inc. (NBIX) Core Values of

Neurocrine Biosciences, Inc. (NBIX) operates with a defined set of core values that guide its actions and decisions. These values reflect the company's commitment to innovation, patients, and ethical conduct. Understanding these values provides insight into how Neurocrine Biosciences approaches its work and its role in the biopharmaceutical industry. You can also learn more about the company's history and mission here: Neurocrine Biosciences, Inc. (NBIX): History, Ownership, Mission, How It Works & Makes Money

Putting Patients First

Neurocrine Biosciences emphasizes a patient-centric approach in all its endeavors. This core value underscores the company's dedication to developing and delivering therapies that address unmet medical needs and improve the lives of patients. The company focuses on neurological, endocrine, and psychiatric disorders, striving to provide solutions where few exist.

Examples of Neurocrine Biosciences' commitment to patients include:

• Developing treatments for conditions like tardive dyskinesia, endometriosis, and Parkinson’s disease.
• Conducting clinical trials with a focus on patient safety and efficacy.
• Collaborating with patient advocacy groups to better understand patient needs and challenges.

Innovation

Innovation is a driving force at Neurocrine Biosciences. The company invests heavily in research and development to discover and advance novel therapies. This commitment to innovation is evident in its pipeline of product candidates and its use of advanced technologies.

Examples of Neurocrine Biosciences' innovation in action:

• Investing $954.1 million in research and development in 2024 to advance its pipeline.
• Focusing on novel therapeutic areas and approaches.
• Seeking out collaborations and partnerships to expand its scientific knowledge and capabilities.

Integrity

Integrity is a cornerstone of Neurocrine Biosciences' operations. The company is committed to conducting business ethically and transparently. This includes adhering to the highest standards of compliance and accountability.

Examples of Neurocrine Biosciences' commitment to integrity include:

• Maintaining a robust compliance program to ensure adherence to laws and regulations.
• Promoting ethical conduct in all aspects of its business.
• Fostering a culture of transparency and accountability.